Feng Chai

Feng Chai is currently employed at Infinity Pharmaceuticals as a Senior Medical Director since October 2020. Prior to that, Feng Chai worked at ArQule for several years in various roles, including Senior Medical Director, Pharmacovigilance and Clinical Development from February 2012 to August 2023, Medical Director, Pharmacovigilance and Clinical Development from July 2009 to February 2012, Associate Medical Director from August 2008 to June 2009, and Clinical Research Scientist from November 2005 to July 2008.

Feng Chai's education history includes a Doctor of Medicine degree from Medical School, Southeast University in Nanjing, China. Additionally, Feng Chai holds a Master of Epidemiology degree from China CDC in Beijing, China. Lastly, Feng Chai obtained a Master of Medical Science in Clinical Investigation from the Massachusetts General Hospital Institute of Health Professions in Boston, MA.